000 | 01260 a2200325 4500 | ||
---|---|---|---|
005 | 20250515125248.0 | ||
264 | 0 | _c20081023 | |
008 | 200810s 0 0 eng d | ||
022 | _a0264-410X | ||
024 | 7 |
_a10.1016/j.vaccine.2008.06.058 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWright, A K A | |
245 | 0 | 0 |
_aProspects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection. _h[electronic resource] |
260 |
_bVaccine _cSep 2008 |
||
300 |
_a4893-903 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Mucosal |
650 | 0 | 4 |
_aInterleukin-12 _xadministration & dosage |
650 | 0 | 4 |
_aPneumococcal Infections _ximmunology |
650 | 0 | 4 |
_aPneumococcal Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aRespiratory Tract Infections _ximmunology |
700 | 1 | _aBriles, D E | |
700 | 1 | _aMetzger, D W | |
700 | 1 | _aGordon, S B | |
773 | 0 |
_tVaccine _gvol. 26 _gno. 38 _gp. 4893-903 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2008.06.058 _zAvailable from publisher's website |
999 |
_c18084773 _d18084773 |